[1]李海军,任静,董良,等.小梁切除术与Ahmed植入术治疗穿透性角膜移植术后继发青光眼的疗效比较[J].眼科新进展,2021,41(2):149-153.[doi:10.13389/j.cnki.rao.2021.0031]
　LI Haijun,REN Jing,DONG Liang,et al.Comparison in clinical outcomes of trabeculectomy and Ahmed glaucoma valve implantation in patients with penetrating keratoplasty[J].Recent Advances in Ophthalmology,2021,41(2):149-153.[doi:10.13389/j.cnki.rao.2021.0031]
点击复制

小梁切除术与Ahmed植入术治疗穿透性角膜移植术后继发青光眼的疗效比较/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
41卷
期数:
2021年2期
页码:
149-153
栏目:
应用研究
出版日期:
2021-02-05

文章信息/Info

Title:
Comparison in clinical outcomes of trabeculectomy and Ahmed glaucoma valve implantation in patients with penetrating keratoplasty
作者:
李海军; 任静; 董良; 杨潇远; 祝磊
450000　河南省郑州市，河南省眼科研究所,河南省人民医院,河南眼科临床研究中心
Author(s):
LI Haijun; REN Jing; DONG Liang; YANG Xiaoyuan; ZHU Lei
Henan Provincial People’s Hospital and Henan Eye Institute,Henan Clinic Research Center of Ophthalmology,Zhengzhou 450000，Henan Province,China
关键词:
穿透性角膜移植术后继发青光眼; 小梁切除术; Ahmed阀植入术; 角膜植片存活率
Keywords:
penetrating keratoplasty glaucoma;  trabeculectomy;  Ahmed glaucoma valve;  corneal graft survival rate
分类号:
R775.4
DOI:
10.13389/j.cnki.rao.2021.0031
文献标志码:
A
摘要:
目的　探讨小梁切除（TRA）术与Ahmed阀（AGV）植入术治疗穿透性角膜移植术后继发青光眼（post-penetrating keratoplasty glaucoma,PKG）的临床疗效与角膜植片安全性。方法　回顾分析我院2015年4月至2018年4月PKG患者47例47眼，按手术方式分TRA组与AGV组，TRA组22例，AGV组25例，随访(24.3±5.2)个月。观察两组患者眼压、并发症、角膜植片状态，以及多因素Cox比例风险回归分析角膜植片预后危险因素。结果　TRA组与AGV组均以感染性角膜病变居多，所占百分比分别为45.45%、52.00%（χ2=0.201，P=0.654）；烧伤次之，所占百分比分别为18.18%、16.00%（P>0.05）。TRA组与AGV组基线眼压分别为(34.95±5.36)mmHg(1 kPa=7.5 mmHg）、（33.93±4.88)mmHg（P=0.231）；末次随访时分别为（21.83±5.14)mmHg 、(17.23±3.93）mmHg，TRA组与AGV组眼压组内术后均较术前降低，术后3个月、1 a、2 a，AGV组较TRA组眼压更低，差异均有统计学意义（均为P<0.05）。 TRA组与AGV组总有效率分别为63.64%、 88.00%（P=0.033）。术后早期以TRA浅前房发生为主，晚期以滤过泡包裹常见，总发生率差异无统计学意义（P=0.057），无严重并发症发生；眼压失控患眼联合睫状体光凝，角膜植片总存活率分别为90.90%、96.00%，组间比较差异无统计学意义（P=0.123）。多因素Cox比例风险模型分析提示，仅感染性病变及眼压反复升高是植片愈合不良风险因素。结论　AGV植入术较TRA术更利于PKG术后眼压控制，且浅前房发生率低，但角膜植片混浊与手术方式无关，感染性病变、术后眼压反复升高是角膜植片混浊的危险因素。
Abstract:
Objective　To observe the clinical outcomes of trabeculectomy and Ahmed glaucoma valve (AGV) implantation in penetrating keratoplasty glaucoma (PKG) patients and the safety of corneal grafts.Methods　A retrospective interventional comparative study was designed. Forty-seven PKG（47 eyes）patients in Henan Provincial People’s Hospital from April 2015 to April 2018 were divided into two group, 22 patient（22 eyes）in trabeculectomy group (TRA group) and 25 patients（25 eyes）in Ahmed glaucoma valve implantation group (AGV group). The follow time was (24.3±5.2) months. The intraocular pressure (IOP), complications, corneal graft survival rates were analyzed, and the risk factors for corneal graft were performed using multivariate Cox regression analysis.Results　Infectious keratitis was the most common primary disease in TRA group and AGV group（45.45% vs. 52.00%, respectively, χ2=0.201，P=0.654）,burning followed（18.18% vs. 16.00%，respectively, P>0.05）. The preoperative IOPs were (34.95±5.36)mmHg （1 kPa=7.5 mmHg） vs.（33.93±4.88)mmHg（P=0.231）, and the last postoperative IOPs were（21.83±5.14)mmHg vs. ( 17.23±3.93）mmHg. Postoperative mean IOP decreased significantly in both groups, and which in AGV group was more lower than TRA group at 3rd months, 1st year and 2nd years, respectively（all P<0.05）. The total success rate was 63.64% vs. 88.00%, respectively（P=0.033）. No server complication occurred, but the early shallow anterior chamber and the later filtering bleb encapsulated occured（χ2=3.166，P=0.075）. Transscleral cyclophotocoagulation was performed for eyes with poor IOP control in both groups, and the overall survival rate of corneal grafts was 90.90%, 96.00%, and the comparison between groups was not statistically significant (Z=-1.544, P=0.123). Although the shallow anterior chamber affected the transparency of corneal implantation, the analysis of the multi-factor cox proportional hazard model suggested that only infectious keratitis，recurrent increased IOP were risk factors for poor graft healing.Conclusion　AGV implantation is more effective to control IOP than trabeculectomy for PKG, and the incidence of shallow anterior chamber is low. However, corneal graft opacity has nothing to do with the operations. Infectious keratitis and recurrent increased IOP are risk factors for graft opacity.

参考文献/References:

［1］　谢立信,史伟云,刘敬，李绍伟,曹景.穿透性角膜移植术后继发性青光眼的临床分析［J］.中华眼科杂志,2000,36(2):116-118.
XIE L X，SHI W Y,LIU J,LI S W,CAO J.Secondary glaucoma after penetrating keratoplasty ［J］.Chin J Ophthalmol,2000,36(2):116-118.
［2］　BALTAZIAK M,CHEW H F,PODBIELSKI D W,AHMED I I K.Glaucoma after corneal replacement［J］.Surv Ophthalmol,2018，63(2):135-148.
［3］　刘艳艳,余涵.原发性急性闭角型青光眼患者持续高眼压状态下行复合式小梁切除术疗效分析［J］.新乡医学院学报,2015,32(2):160-162.
LIU Y Y,YU H.Effect of compound trabeculectomy on acute primary angle closure glaucoma under continuous high intraocular pressure state［J］ .J Xinxiang Med Univ,2015,32(2):160-162.
［4］　QUEK D T,WONG C W,WONG T T,HAN S B,HTOON H M,HO C L,et al.Graft failure and intraocular pressure control after keratoplasty in iridocorneal endothelial syndrome［J］.Am J Ohthalmol,2015，160(3):422-429 e1.
［5］　TANDON A,ESPANDAR L,CUPP D,HO S,JOHNSON V,AYYALA R S.Surgical management for postkeratoplasty glaucoma:a meta-analysis［J］.J Glaucoma,2014，23(7):424-429.
［6］　SIHOTA R,SRINIVASAN G,GUPTA V.Ab-externo cyclodialysis enhanced trabeculectomy for intractable post-penetrating keratoplasty glaucoma［J］.Eye,2010，24(6):976-979.
［7］　ALP M N,YARANGUMELI A,KOZ O G,KURAL G.Nd:YAG laser goniopuncture in viscocanalostomy:penetration in non-penetrating glaucoma surgery［J］.Int Ophthalmol,2010，30(3):245-252.
［8］　ELHOFI A,HELALY H A.Graft survival after penetrating keratoplasty in cases of trabeculectomy versus Ahmed valve implant［J］.J Ophthalmol,2018，2018:9034964.
［9］　AKDEMIR M O,ACAR B T,KOKTURK F,ACAR S.Clinical outcomes of trabeculectomy vs.Ahmed glaucoma valve implantation in patients with penetrating keratoplasty:(Trabeculectomy vs Ahmed galucoma valve in patients with penetrating keratoplasty)［J］.Int Ophthalmol,2016，36(4):541-546.
［10］　AIMOUSA R,NANAVATY M A,DAYA S M,LAKE D B.Intraocular pressure control and corneal graft survival after implantation of Ahmed valve device in high-risk penetrating keratoplasty［J］.Cornea,2013，32(8):1099-1104.
［11］　尹文惠,李素霞,董春晓,冯莉娟,刘敏,王欣,等.穿透性角膜移植术后发生继发性青光眼的影响因素及治疗方法［J］.眼科新进展,2020,40(3):230-234.
YIN W H，LI S X，DONG C X,FENG L J,LIU M,WANG X,et al.Influential factors and effect analysis of treatment for secondary glaucoma after penetrating keratoplasty ［J］.Ｒec Adv Ophthalmol,2020,40(3):230-234.
［12］　王正艳,李凤洁,赵灿，王利英，王婷.穿透性角膜移植术后继发性青光眼行小梁切除术的临床观察［J］.临床眼科杂志,2020,28(1):1-5.
WANG Z Y,LI F J,ZHAO C,WANG L Y,WANG T.Clinical observation of trabeculectomy on patients with secondary glaucoma after penetrating keratoplasty［J］.J Clin Ophthalmol，2020,28(1):1-5.
［13］　COLEMAN A L,MONDINO B J,WILSON M R,CASEY R,CASEY R.Clinical experience with the Ahmed glaucoma valve implant in eyes with prior or concurrent penetrating keratoplasties［J］.Am J Ophthalmol,1997，123(1):54-61.
［14］　李霞,高晓唯,张燕,王瑞夫,黄玲华,王梦斐.经巩膜TCP术治疗近穿孔角膜溃疡继发青光眼的探讨［J］.临床眼科杂志,2017,25(2):117-120.
LI X,GAO X W,ZHANG Y,WANG R F,HUANG L H,WANG M F.Trans-scleral cyclophotocoagulation to treat secondary glaucoma in nearly perforated corneal ulcer［J］.J Clin Ophthalmol,2017,25(2):117-120.
［15］　关卫卫,张煜晨,张远平,赵学英.穿透性角膜移植术后移植片的转归［J］.临床眼科杂志,2001，9(3):188-190.
GUAN W W,ZHANG Y C,ZHANG Y P,ZHAO X Y.The change of graft opacity after penetrating cornea transplanation［J］.J Clin Ophthalmol,2001，9(3):188-190.
［16］　PATEL M,SAID D,DUA H.Graft failure after penetrating keratoplasty in eyes with Ahmed valves［J］.Am J Ophthalmol,2011，151(2):382-383.
［17］　YAKIN M,EKSIOGLU U,YALNIZ-AKKAYA Z,UZMAN S,SINGAR-QZDEMIR E,GULTEKIN K,et al.Outcomes of trabeculectomy and glaucoma drainage devices for elevated intraocular pressure after penetrating keratoplasty［J］.Cornea,2018，37(6):705-711.

相似文献/References:

[1]胡馨 王永毅 赵博.双切口联合手术治疗青光眼合并白内障临床疗效观察[J].眼科新进展,2012,32(4):000.
[2]田甜 刘伟 安琳 李丹丹 邢小丽 刘爱华 季健.晶状体前囊膜应用于兔眼超声乳化联合小梁切除术的实验研究[J].眼科新进展,2012,32(5):000.
[3]王勤 罗顺利.不同抗青光眼手术后浅前房发生率比较及原因分析[J].眼科新进展,2012,32(5):000.
[4]徐冰 董宁 肖林 褚利群 徐景美 王冰松.不同剂量曲安奈德前房注射抑制青光眼联合白内障手术后前葡萄膜炎的临床研究[J].眼科新进展,2012,32(6):000.
[5]马红利 李世洋 赵爱红 蒋骁男 陈萍.尿毒症血液透析继发新生血管性青光眼的治疗[J].眼科新进展,2012,32(8):000.
[6]刘海凤 朱晓谦 余涵.青光眼术后低角膜内皮细胞密度白内障手术26例临床分析[J].眼科新进展,2012,32(8):000.
[7]梁永强.超声乳化联合房角分离术与小梁切除术治疗原发性闭角型青光眼的疗效比较[J].眼科新进展,2013,33(2):000.
[8]李维娜 张育谋 李学喜 魏锐利.原发性急性闭角型青光眼持续性高眼压睫状体光凝后行小梁切除术的疗效观察[J].眼科新进展,2013,33(5):000.
[9]王建萍 马勇 薛雨顺 车选义 张德秀.小梁切除术后房水和晶状体中转化生长因子-β2含量的变化[J].眼科新进展,2013,33(10):000.
[10]谭思敏 李瑞庄 黎宗汉 方林彬.原发性青光眼滤过术后发生恶性青光眼的危险因素分析[J].眼科新进展,2013,33(12):000.

备注/Memo

备注/Memo:
国家自然科学基金项目（编号：U1904166）；河南省省部共建项目（编号：SBGJ2018072）
更新日期/Last Update: 2021-02-05